HER-2 protein overexpression
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB06626 | Axitinib | 1 | Enrolling by Invitation | 1 |
| DB17573 | Evorpacept | 1 | Recruiting | 1 |
| DB09035 | Nivolumab | 1 | Recruiting | 1 |
| DB01229 | Paclitaxel | 1 | Withdrawn | 1 |
| DB09037 | Pembrolizumab | 1 | Active Not Recruiting | 1 |
| DB09037 | Pembrolizumab | 1 | Recruiting | 1 |
| DB06366 | Pertuzumab | 1 | Recruiting | 1 |
| DB00072 | Trastuzumab | 1 | Terminated | 1 |
| DB14962 | Trastuzumab deruxtecan | 1 | Recruiting | 1 |
| DB16342 | Trastuzumab duocarmazine | 1 | Withdrawn | 1 |
| DB11652 | Tucatinib | 1 | Recruiting | 1 |
| DB15471 | Zanidatamab | 1 | Recruiting | 1 |
| DB00002 | Cetuximab | 1 / 2 | Withdrawn | 1 |
| DB17208 | Disitamab vedotin | 1 / 2 | Not Yet Recruiting | 1 |
| DB12257 | Platinum | 1 / 2 | Not Yet Recruiting | 1 |
| DB00072 | Trastuzumab | 1 / 2 | Withdrawn | 1 |
| DB17208 | Disitamab vedotin | 2 | Not Yet Recruiting | 1 |
| DB00441 | Gemcitabine | 2 | Unknown Status | 1 |
| DB00762 | Irinotecan | 2 | Unknown Status | 1 |
| DB09035 | Nivolumab | 2 | Recruiting | 1 |
| DB14993 | Pyrotinib | 2 | Unknown Status | 1 |
| DB00072 | Trastuzumab | 2 | Completed | 1 |
| DB00072 | Trastuzumab | 2 | Recruiting | 1 |
| DB00072 | Trastuzumab | 2 | Unknown Status | 1 |
| DB14962 | Trastuzumab deruxtecan | 2 | Recruiting | 1 |